1. Home
  2. EMBC vs AQST Comparison

EMBC vs AQST Comparison

Compare EMBC & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$9.63

Market Cap

602.3M

Sector

Health Care

ML Signal

HOLD

Logo Aquestive Therapeutics Inc.

AQST

Aquestive Therapeutics Inc.

N/A

Current Price

$4.36

Market Cap

707.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EMBC
AQST
Founded
1924
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
602.3M
707.6M
IPO Year
2021
2007

Fundamental Metrics

Financial Performance
Metric
EMBC
AQST
Price
$9.63
$4.36
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$18.50
$8.83
AVG Volume (30 Days)
905.0K
2.2M
Earning Date
01-01-0001
06-08-2026
Dividend Yield
6.24%
N/A
EPS Growth
20.90
N/A
EPS
0.74
N/A
Revenue
N/A
$67,430,000.00
Revenue This Year
$1.17
N/A
Revenue Next Year
N/A
$11.33
P/E Ratio
$13.01
N/A
Revenue Growth
N/A
0.77
52 Week Low
$9.20
$2.20
52 Week High
$15.55
$7.55

Technical Indicators

Market Signals
Indicator
EMBC
AQST
Relative Strength Index (RSI) 33.73 57.47
Support Level $9.45 $3.69
Resistance Level $10.88 $4.44
Average True Range (ATR) 0.35 0.21
MACD -0.02 0.09
Stochastic Oscillator 2.67 89.29

Price Performance

Historical Comparison
EMBC
AQST

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Share on Social Networks: